A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)

Clinical trial NCT02079636 · COMPLETED

Trial details

NCT number: NCT02079636
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-small Cell Lung

Start date: 2014-03-28
Primary completion: 2018-05-02
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.